Exchange: NASDAQ·Updated 07:58 PM EDT
VRAX logo

VRAX Virax Biolabs Group Ltd

$2.91
$0.09
(3.00%)
Today
Closed $2.91
$0.00
(0.00%)
After Hours
Mkt Cap$2.39M
Vol36,227.00

About VRAX

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
56

Bullish Sentiment

How do you feel about VRAX?

Community Summary

Community sentiment on VRAX is heavily bearish, with many accusing it of being a pump-and-dump scam and highlighting the stock's plunge from $14 to $4 after a reverse split, while a smaller group points to catalysts like the Fosun supply deal and an upcoming investor webinar as potential squeeze triggers.

Last updated: 15m agoAI generated, may contain errors

Advertisement|Remove ads.